<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">22585091</PMID>
      <DateCompleted>
        <Year>2012</Year>
        <Month>10</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1945-7197</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>97</Volume>
            <Issue>8</Issue>
            <PubDate>
              <Year>2012</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Journal of clinical endocrinology and metabolism</Title>
          <ISOAbbreviation>J Clin Endocrinol Metab</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Differential gene expression by oxyphil and chief cells of human parathyroid glands.</ArticleTitle>
        <Pagination>
          <StartPage>E1499</StartPage>
          <EndPage>E1505</EndPage>
          <MedlinePgn>E1499-505</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1210/jc.2011-3366</ELocationID>
        <Abstract>
          <AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Parathyroid oxyphil cells, whose function is unknown, are thought to be derived from chief cells. Oxyphil cells increase in number in parathyroid glands of patients with chronic kidney disease (CKD) and are even more abundant in patients receiving treatment for hyperparathyroidism with calcitriol and/or the calcimimetic cinacalcet.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We examined oxyphil and chief cells of parathyroid glands of CKD patients for differential expression of genes important to parathyroid function.</AbstractText>
          <AbstractText Label="DESIGN/SETTING/PARTICIPANTS" NlmCategory="METHODS">Parathyroid tissue from CKD patients with refractory hyperparathyroidism was immunostained for gene expression studies.</AbstractText>
          <AbstractText Label="MAIN OUTCOME MEASURE" NlmCategory="METHODS">Immunostaining for PTH, PTHrP, calcium-sensing receptor, glial cells missing 2, vitamin D receptor, 25-hydroxyvitamin D-1α-hydroxylase, and cytochrome c was quantified and expression reported for oxyphil and chief cells.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Expression of all proteins analyzed, except for the vitamin D receptor, was higher in oxyphil cells than in chief cells.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Human parathyroid oxyphil cells express parathyroid-relevant genes found in the chief cells and have the potential to produce additional autocrine/paracrine factors, such as PTHrP and calcitriol. Additional studies are warranted to define the secretory properties of these cells and clarify their role in parathyroid pathophysiology.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ritter</LastName>
            <ForeName>Cynthia S</ForeName>
            <Initials>CS</Initials>
            <AffiliationInfo>
              <Affiliation>Renal Division, Washington University School of Medicine, Barnes Jewish Hospital, St Louis, Missouri 63110, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Haughey</LastName>
            <ForeName>Bruce H</ForeName>
            <Initials>BH</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miller</LastName>
            <ForeName>Brent</ForeName>
            <Initials>B</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Brown</LastName>
            <ForeName>Alex J</ForeName>
            <Initials>AJ</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>P30 DK020579</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P60 DK020579</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>DK-20579</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2012</Year>
          <Month>05</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Clin Endocrinol Metab</MedlineTA>
        <NlmUniqueID>0375362</NlmUniqueID>
        <ISSNLinking>0021-972X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C119532">GCM2 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010281">Parathyroid Hormone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D044162">Parathyroid Hormone-Related Protein</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018167">Receptors, Calcitriol</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D044169">Receptors, Calcium-Sensing</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020869" MajorTopicYN="Y">Gene Expression Profiling</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024862" MajorTopicYN="N">Oxyphil Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010280" MajorTopicYN="N">Parathyroid Glands</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010281" MajorTopicYN="N">Parathyroid Hormone</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D044162" MajorTopicYN="N">Parathyroid Hormone-Related Protein</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018167" MajorTopicYN="N">Receptors, Calcitriol</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D044169" MajorTopicYN="N">Receptors, Calcium-Sensing</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2012</Year>
          <Month>5</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2012</Year>
          <Month>5</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2012</Year>
          <Month>10</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">22585091</ArticleId>
        <ArticleId IdType="pmc">PMC3591682</ArticleId>
        <ArticleId IdType="doi">10.1210/jc.2011-3366</ArticleId>
        <ArticleId IdType="pii">jc.2011-3366</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Christie AC.
1967. 
The parathyroid oxyphil cells. J Clin Pathol
20:591–602</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC473518</ArticleId>
            <ArticleId IdType="pubmed">4880406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hamperl H.
1962. 
[Onkocytes and onkocytoma]. Virchows Arch Pathol Anat Physiol Klin Med
335:452–483
(German)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13904234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tanaka Y, Funahashi H, Imai T, Seo H, Tominaga Y, Takagi H.
1996. 
Oxyphil cell function in secondary parathyroid hyperplasia. Nephron
73:580–586</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8856255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Nonaka D.
2011. 
Study of parathyroid transcription factor Gcm2 expression in parathyroid lesions. Am J Surg Pathol
35:145–151</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21164298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lomonte C, Martino R, Selvaggiolo M, Bona RM, Cazzato F, Milano R, Chiarulli G, Basile C.
2003. 
Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients. J Nephrol
16:716–720</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14733419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lomonte C, Vernaglione L, Chimienti D, Bruno A, Cocola S, Teutonico A, Cazzato F, Basile C.
2008. 
Does vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of parathyroid glands in refractory uremic hyperparathyroidism?
Clin J Am Soc Nephrol
3:794–799</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2386693</ArticleId>
            <ArticleId IdType="pubmed">18322048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sumida K, Nakamura M, Ubara Y, Marui Y, Tanaka K, Takaichi K, Tomikawa S, Inoshita N, Ohashi K.
2011. 
Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride. J Clin Pathol
64:756–760</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21565858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kitazawa R, Kitazawa S, Fukase M, Fujita T, Kobayashi A, Chihara K, Maeda S.
1992. 
The expression of parathyroid hormone-related protein (PTHrP) in normal parathyroid: histochemistry and in situ hybridization. Histochemistry
98:211–215</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1459860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kitazawa R, Kitazawa S, Maeda S, Kobayashi A.
2002. 
Expression of parathyroid hormone-related protein (PTHrP) in parathyroid tissue under normal and pathological conditions. Histol Histopathol
17:179–184</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11813867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Matsushita H, Hara M, Endo Y, Shishiba Y, Hara S, Ubara Y, Nakazawa H, Suzuki N, Kawaminami K, Kido T, Li Q, Grimelius L.
1999. 
Proliferation of parathyroid cells negatively correlates with expression of parathyroid hormone-related protein in secondary parathyroid hyperplasia. Kidney Int
55:130–138</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9893121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lewin E, Almaden Y, Rodriguez M, Olgaard K.
2000. 
PTHrP enhances the secretory response of PTH to a hypocalcemic stimulus in rat parathyroid glands. Kidney Int
58:71–81</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10886551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lewin E, Garfia B, Almaden Y, Rodriguez M, Olgaard K.
2003. 
Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats. Kidney Int
64:63–70</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12787396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kremer R, Sebag M, Champigny C, Meerovitch K, Hendy GN, White J, Goltzman D.
1996. 
Identification and characterization of 1,25-dihydroxyvitamin D3-responsive repressor sequences in the rat parathyroid hormone-related peptide gene. J Biol Chem
271:16310–16316</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8663213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
MacLeod RJ, Chattopadhyay N, Brown EM.
2003. 
PTHrP stimulated by the calcium-sensing receptor requires MAP kinase activation. Am J Physiol Endocrinol Metab
284:E435–E442</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12388158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chattopadhyay N.
2006. 
Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy. Am J Physiol Endocrinol Metab
290:E761–E770</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16603723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
VanHouten J, Dann P, McGeoch G, Brown EM, Krapcho K, Neville M, Wysolmerski JJ.
2004. 
The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport. Journal of Clin Invest
113:598–608</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC338258</ArticleId>
            <ArticleId IdType="pubmed">14966569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ardeshirpour L, Dann P, Pollak M, Wysolmerski J, VanHouten J.
2006. 
The calcium-sensing receptor regulates PTHrP production and calcium transport in the lactating mammary gland. Bone
38:787–793</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16377269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mamillapalli R, VanHouten J, Zawalich W, Wysolmerski J.
2008. 
Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells. J Biol Chem
283:24435–24447</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2528989</ArticleId>
            <ArticleId IdType="pubmed">18621740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Brown AJ, Ritter CS, Finch JL, Slatopolsky EA.
1999. 
Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. Kidney Int
55:1284–1292</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10200992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ritter CS, Haughey BH, Armbrecht HJ, Brown AJ.
2012. 
Distribution and regulation of the 25-hydroxyvitamin D3 1α-hydroxylase in human parathyroid glands. J Steroid Biochem Mol Biol
130:73–80</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22326730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mizobuchi M, Ritter CS, Krits I, Slatopolsky E, Sicard G, Brown AJ.
2009. 
Calcium-sensing receptor expression is regulated by glial cells missing-2 in human parathyroid cells. J Bone Miner Res
24:1173–1179</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2697623</ArticleId>
            <ArticleId IdType="pubmed">19257819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Munger BL, Roth SI.
1963. 
The cytology of the normal parathyroid glands of man and Virginia deer; a light and electron microscopic study with morphologic evidence of secretory activity. J Cell Biol
16:379–400</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2106251</ArticleId>
            <ArticleId IdType="pubmed">13936618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Müller-Höcker J, Schäfer S, Copeland WC, Wiesner R, Seibel P.
1998. 
Immunohistochemical detection of human mtDNA polymerase γ and of human mitochondrial transcription factor A in cytochrome-c-oxidase-deficient oxyphil cells of hyperfunctional parathyroids. Virchows Archiv
433:529–536</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9870686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Günther T, Chen ZF, Kim J, Priemel M, Rueger JM, Amling M, Moseley JM, Martin TJ, Anderson DJ, Karsenty G.
2000. 
Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature
406:199–203</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10910362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Correa P, Akerstrom G, Westin G.
2002. 
Underexpression of Gcm2, a master regulatory gene of parathyroid gland development, in adenomas of primary hyperparathyroidism. Clin Endocrinol (Oxf)
57:501–505</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12354132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kebebew E, Peng M, Wong MG, Ginzinger D, Duh QY, Clark OH.
2004. 
GCMB gene, a master regulator of parathyroid gland development, expression, and regulation in hyperparathyroidism. Surgery
136:1261–1266</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15657585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Allen TB, Thorburn KM.
1981. 
The oxyphil cell in abnormal parathyroid glands. A study of 114 cases. Arch Pathol Lab Med
105:421–427</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6894851</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Fletcher S, Brownjohn AM, Dunwell C, Harnden P.
1997. 
Immunocytochemical detection of a reduction in 1,25 dihyroxyvitamin D3 receptor expression in uraemic parathyroid tissue. Nephrol Dial Transplant
12:93–96</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9027780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rodriguez M, Nemeth E, Martin D.
2005. 
The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism. Am J Physiol Renal Physiol
288:F253–F264</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15507543</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kifor O, Moore FD, Jr, Wang P, Goldstein M, Vassilev P, Kifor I, Hebert SC, Brown EM.
1996. 
Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab
81:1598–1606</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8636374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gogusev J, Duchambon P, Hory B, Giovannini M, Goureau Y, Sarfati E, Drüeke TB.
1997. 
Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int
51:328–336</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8995751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Korkor AB.
1987. 
Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. N Engl J Med
316:1573–1577</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3035373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y.
1993. 
Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest
92:1436–1443</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC288288</ArticleId>
            <ArticleId IdType="pubmed">8397225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Grzela T, Chudzinski W, Lasiecka Z, Niderla J, Wilczynski G, Gornicka B, Wasiutynski A, Durlik M, Boszczyk A, Brawura-Biskupski-Samaha R, Dziunycz P, Milewski L, Lazarczyk M, Lazarczyk M, Nawrot I.
2006. 
The calcium-sensing receptor and vitamin D receptor expression in tertiary hyperparathyroidism. Int J Mol Med
17:779–783</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16596260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Välimäki S, Farnebo F, Forsberg L, Larsson C, Farnebo LO.
2001. 
Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism. Kidney Int
60:1666–1675</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11703583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mizobuchi M, Hatamura I, Ogata H, Saji F, Uda S, Shiizaki K, Sakaguchi T, Negi S, Kinugasa E, Koshikawa S, Akizawa T.
2004. 
Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency. J Am Soc Nephrol
15:2579–2587</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15466262</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
